CR9993A - Formulación de suspensión de fexofenadina - Google Patents
Formulación de suspensión de fexofenadinaInfo
- Publication number
- CR9993A CR9993A CR9993A CR9993A CR9993A CR 9993 A CR9993 A CR 9993A CR 9993 A CR9993 A CR 9993A CR 9993 A CR9993 A CR 9993A CR 9993 A CR9993 A CR 9993A
- Authority
- CR
- Costa Rica
- Prior art keywords
- suspension formulation
- fexofenadine
- fexofenadine suspension
- dihydrate
- directed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75030305P | 2005-12-14 | 2005-12-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR9993A true CR9993A (es) | 2008-09-23 |
Family
ID=38120312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR9993A CR9993A (es) | 2005-12-14 | 2008-05-20 | Formulación de suspensión de fexofenadina |
Country Status (38)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101546774B1 (ko) | 2008-07-29 | 2015-08-24 | 엘지전자 주식회사 | 휴대 단말기 및 그 동작제어 방법 |
| BR112014009547A8 (pt) | 2011-10-19 | 2018-01-23 | Scherer Technologies Llc R P | composição farmacêutica para administração oral, e, sistema de liberação para a administração oral de uma composição farmacêutica bifásica |
| EP3016635A1 (en) * | 2013-07-01 | 2016-05-11 | Aventisub LLC | Liquid pharmaceutical composition for oral administration comprising fexofenadine |
| WO2015003109A1 (en) * | 2013-07-03 | 2015-01-08 | R.P. Scherer Technologies, Llc | Capsule formulation comprising fexofenadine |
| CN103610645B (zh) * | 2013-11-25 | 2016-05-11 | 浙江万晟药业有限公司 | 一种非索非那定盐酸盐的药物组合物及制备方法 |
| CN106806346B (zh) * | 2015-12-01 | 2020-09-11 | 国药集团广东环球制药有限公司 | 一种非索非那定盐酸盐干混悬剂制剂及其制备方法 |
| CN109906079B (zh) * | 2016-06-16 | 2022-09-30 | 库蒂斯制药公司 | 用于质子泵抑制剂混悬剂的组合物和方法 |
| CN110730656B (zh) | 2017-06-02 | 2022-09-16 | 特一华制药株式会社 | 水难溶性成分增溶胶束及含有该胶束的液体制剂 |
| US10751333B1 (en) | 2019-07-16 | 2020-08-25 | Cutispharma, Inc. | Compositions and kits for omeprazole suspension |
| US11633478B2 (en) | 2019-07-16 | 2023-04-25 | Azurity Pharmaceuticals, Inc. | Compositions and kits for Omeprazole suspension |
| WO2022038474A1 (en) * | 2020-08-18 | 2022-02-24 | Innate S.R.L. | Injectable composition and use of said composition |
| WO2022175829A1 (en) | 2021-02-17 | 2022-08-25 | Cellix Bio Private Limited | Topical formulations and compositions |
| EP4456880A1 (en) * | 2021-12-29 | 2024-11-06 | Opella Healthcare Group SAS | Compositions containing fexofenadine |
| CN115715759B (zh) * | 2022-11-03 | 2024-01-12 | 京海盛达(北京)科技有限公司 | 一种抗组胺混悬剂及其制备方法 |
| CR20240566A (es) | 2023-01-20 | 2025-02-25 | Opella Healthcare Group Sas | Formulaciones de fexofenadina sin parabenos |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
| US4829064A (en) | 1987-06-08 | 1989-05-09 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
| EP0766668B1 (en) * | 1994-05-18 | 2002-07-17 | Aventis Pharmaceuticals Inc. | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof |
| US6132758A (en) | 1998-06-01 | 2000-10-17 | Schering Corporation | Stabilized antihistamine syrup |
| US6319513B1 (en) * | 1998-08-24 | 2001-11-20 | The Procter & Gamble Company | Oral liquid mucoadhesive compounds |
| GB9822170D0 (en) | 1998-10-13 | 1998-12-02 | Danbioyst Uk Ltd | Novel formulations of fexofenadine |
| US20060083691A1 (en) * | 2000-05-10 | 2006-04-20 | Wermeling Daniel P | Intranasal opioid compositions, delivery devices and methods of using same |
| PT1414453E (pt) | 2001-07-31 | 2008-05-29 | Texcontor Ets | Polimorfo de cloridrato de fexofenadina |
| US6723348B2 (en) * | 2001-11-16 | 2004-04-20 | Ethypharm | Orodispersible tablets containing fexofenadine |
| MXPA05008193A (es) | 2003-01-30 | 2006-05-25 | Ethypharm Sa | Particulas con revestimiento que oculta el sabor, proceso para la preparacion de las mismas y tabletas orodispersables que contienen dichas particulas revestidas. |
| US20050250737A1 (en) * | 2003-11-12 | 2005-11-10 | Allergan, Inc. | Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
| US20050266031A1 (en) | 2004-05-25 | 2005-12-01 | Jay Dickerson | Pharmaceutical suspension composition |
| PL2486942T3 (pl) * | 2004-11-24 | 2019-05-31 | Meda Pharmaceuticals Inc | Kompozycje zawierające azelastynę oraz sposoby ich stosowania |
| EP1910294A1 (en) | 2005-07-27 | 2008-04-16 | Sandoz AG | A process for the preparation of substituted phenyl ether compounds and rosiglitazone |
| JP5133244B2 (ja) * | 2005-08-05 | 2013-01-30 | ルピン・リミテッド | フェキソフェナジンの経口用医薬懸濁組成物 |
-
2006
- 2006-12-06 DO DO2006000274A patent/DOP2006000274A/es unknown
- 2006-12-12 RU RU2008128418/15A patent/RU2405538C2/ru not_active IP Right Cessation
- 2006-12-12 BR BRPI0619895-3A patent/BRPI0619895B1/pt active IP Right Grant
- 2006-12-12 DK DK06839331T patent/DK1965768T3/da active
- 2006-12-12 AU AU2006326551A patent/AU2006326551B2/en active Active
- 2006-12-12 EP EP06839331A patent/EP1965768B1/en active Active
- 2006-12-12 AT AT06839331T patent/ATE431137T1/de active
- 2006-12-12 JP JP2008545740A patent/JP5308824B2/ja not_active Expired - Fee Related
- 2006-12-12 SI SI200630374T patent/SI1965768T1/sl unknown
- 2006-12-12 HR HR20090411T patent/HRP20090411T1/hr unknown
- 2006-12-12 UA UAA200809121A patent/UA89584C2/uk unknown
- 2006-12-12 DE DE602006006870T patent/DE602006006870D1/de active Active
- 2006-12-12 WO PCT/US2006/047393 patent/WO2007070517A2/en not_active Ceased
- 2006-12-12 NZ NZ568943A patent/NZ568943A/en not_active IP Right Cessation
- 2006-12-12 ES ES06839331T patent/ES2327168T3/es active Active
- 2006-12-12 PE PE2006001593A patent/PE20071003A1/es not_active Application Discontinuation
- 2006-12-12 KR KR1020087014471A patent/KR101452792B1/ko not_active Expired - Fee Related
- 2006-12-12 CA CA2633086A patent/CA2633086C/en active Active
- 2006-12-12 RS RSP-2009/0360A patent/RS51135B/sr unknown
- 2006-12-12 PT PT06839331T patent/PT1965768E/pt unknown
- 2006-12-12 AR ARP060105470A patent/AR058323A1/es not_active Application Discontinuation
- 2006-12-12 CN CN200680044516XA patent/CN101316580B/zh active Active
- 2006-12-12 MY MYPI20081743A patent/MY146988A/en unknown
- 2006-12-12 PL PL06839331T patent/PL1965768T3/pl unknown
- 2006-12-14 JO JO2006458A patent/JO2549B1/en active
- 2006-12-14 TW TW095146788A patent/TWI377061B/zh not_active IP Right Cessation
- 2006-12-15 UY UY30021A patent/UY30021A1/es not_active Application Discontinuation
-
2008
- 2008-04-24 TN TNP2008000186A patent/TNSN08186A1/en unknown
- 2008-05-06 ZA ZA200803985A patent/ZA200803985B/xx unknown
- 2008-05-20 CR CR9993A patent/CR9993A/es not_active Application Discontinuation
- 2008-06-11 IL IL192067A patent/IL192067A/en not_active IP Right Cessation
- 2008-06-12 EC EC2008008532A patent/ECSP088532A/es unknown
- 2008-06-13 US US12/138,468 patent/US8933097B2/en active Active
- 2008-06-13 HN HN2008000875A patent/HN2008000875A/es unknown
- 2008-06-15 EG EG2008060996A patent/EG25866A/xx active
- 2008-06-26 NO NO20082904A patent/NO339877B1/no not_active IP Right Cessation
- 2008-07-11 MA MA31103A patent/MA30152B1/fr unknown
-
2009
- 2009-08-12 CY CY20091100862T patent/CY1109320T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR9993A (es) | Formulación de suspensión de fexofenadina | |
| HRP20120323T1 (en) | Diarylhydantoin compounds | |
| SG161311A1 (en) | Novel use of spiegelmers | |
| DOP2011000399A (es) | Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17 | |
| ES2531093T3 (es) | Procedimiento de preparación de halogenuros de N-alquil-naltrexona | |
| UA105229C2 (uk) | Фармацевтичний склад | |
| CY1115199T1 (el) | Κυτταροτοξικοι παραγοντες που περιεχουν νεα παραγωγα τομαϋμυκινης και η θεραπευτικη τους χρηση | |
| AU2012259422A8 (en) | Solid forms of a pharmaceutically active substance | |
| GT200600084A (es) | Forma cristalina beta de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen | |
| ECSP11011224A (es) | Derivados de tiadiazoles y oxadiazoles, su preparaciòn y su aplicaciòn en terapia | |
| ECSP088689A (es) | NOVEDOSAS 11ß-HIDROXIANDROSTA-4-EN-3-ONAS | |
| ECSP066376A (es) | FORMA CRISTALINA GAMMA-d DEL CLORHIDRATO DE IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN | |
| CO6821935A2 (es) | Derivados novedosos de cefalosporinas y cmposiciones farmacéuticas de estos | |
| GT200500360A (es) | Compuestos organicos | |
| UY29857A1 (es) | Derivados de la 4-amino-quinazolina, su preparación y su aplicación en terapéutica. | |
| BR122016006880B8 (pt) | forma de dosagem contendo pantoprazol como ingrediente ativo | |
| JO3192B1 (ar) | مركب بنزوثيازولون | |
| ECSP088374A (es) | Formulacion de aerosol para inhalacion | |
| UY29859A1 (es) | Derivados de 1-amino-isiquinolina,su preparación y su aplicación terapéutica | |
| GT200500031A (es) | Procesos para la preparacion de haluros de arilalquilsulfonilo y haluros de heteroarilalquilsulfonilo | |
| NO20082973L (no) | Salter av styfninsyre | |
| WO2007138462A3 (en) | Aqueous oral formulations of risperidone | |
| ATE535230T1 (de) | Fosphenytoin-zusammensetzung | |
| DOP2006000130A (es) | Inhibidores de la adenilato ciclasa soluble | |
| CR9435A (es) | Uso de un compuesto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |